Journal Article
. 2018 Sep; 19(10):1385-1393.
doi: 10.1016/S1470-2045(18)30380-2.

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti 1 Bernard F Cole 2 Giuseppe Viale 3 Paolo Veronesi 4 Elisa Vicini 5 Mattia Intra 5 Giovanni Mazzarol 6 Samuele Massarut 7 Janez Zgajnar 8 Mario Taffurelli 9 David Littlejohn 10 Michael Knauer 11 Carlo Tondini 12 Angelo Di Leo 13 Marco Colleoni 5 Meredith M Regan 14 Alan S Coates 15 Richard D Gelber 16 Aron Goldhirsch 17 International Breast Cancer Study Group Trial 23-01  
Affiliations
  • PMID: 30196031
  •     60 citations

Abstract

Background: We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more micrometastatic (≤2 mm) sentinel nodes randomly assigned to either axillary dissection or no axillary dissection. The results showed no difference in disease-free survival between the groups and showed non-inferiority of no axillary dissection relative to axillary dissection. The current analysis presents the results of the study after a median follow-up of 9·7 years (IQR 7·8-12·7).

Methods: In this multicentre, randomised, controlled, open-label, non-inferiority, phase 3 trial, participants were recruited from 27 hospitals and cancer centres in nine countries. Eligible women could be of any age with clinical, mammographic, ultrasonographic, or pathological diagnosis of breast cancer with largest lesion diameter of 5 cm or smaller, and one or more metastatic sentinel nodes, all of which were 2 mm or smaller and with no extracapsular extension. Patients were randomly assigned (1:1) before surgery (mastectomy or breast-conserving surgery) to no axillary dissection or axillary dissection using permuted blocks generated by a web-based congruence algorithm, with stratification by centre and menopausal status. The protocol-specified primary endpoint was disease-free survival, analysed in the intention-to-treat population (as randomly assigned). Safety was assessed in all randomly assigned patients who received their allocated treatment (as treated). We did a one-sided test for non-inferiority of no axillary dissection by comparing the observed hazard ratios (HRs) for disease-free survival with a margin of 1·25. This 10-year follow-up analysis was not prespecified in the trial's protocol and thus was not adjusted for multiple, sequential testing. This trial is registered with ClinicalTrials.gov, number NCT00072293.

Findings: Between April 1, 2001, and Feb 8, 2010, 6681 patients were screened and 934 randomly assigned to no axillary dissection (n=469) or axillary dissection (n=465). Three patients were ineligible and were excluded from the trial after randomisation. Disease-free survival at 10 years was 76·8% (95% CI 72·5-81·0) in the no axillary dissection group, compared with 74·9% (70·5-79·3) in the axillary dissection group (HR 0·85, 95% CI 0·65-1·11; log-rank p=0·24; p=0·0024 for non-inferiority). Long-term surgical complications included lymphoedema of any grade in 16 (4%) of 453 patients in the no axillary dissection group and 60 (13%) of 447 in the axillary dissection group, sensory neuropathy of any grade in 57 (13%) in the no axillary dissection group versus 85 (19%) in the axillary dissection group, and motor neuropathy of any grade (14 [3%] in the no axillary dissection group vs 40 [9%] in the axillary dissection group). One serious adverse event (postoperative infection and inflamed axilla requiring hospital admission) was attributed to axillary dissection; the event resolved without sequelae.

Interpretation: The findings of the IBCSG 23-01 trial after a median follow-up of 9·7 years (IQR 7·8-12·7) corroborate those obtained at 5 years and are consistent with those of the 10-year follow-up analysis of the Z0011 trial. Together, these findings support the current practice of not doing an axillary dissection when the tumour burden in the sentinel nodes is minimal or moderate in patients with early breast cancer.

Funding: International Breast Cancer Study Group.

Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients.
Yuanxin Zhang, Ji Li, +4 authors, Hongjiang Li.
Medicine (Baltimore), 2019 Oct 03; 98(40). PMID: 31577783    Free PMC article.
Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation.
Mizuho Abe, Naofumi Kagara, +6 authors, Shinzaburo Noguchi.
Oncol Rep, 2019 Oct 23; 42(6). PMID: 31638213    Free PMC article.
NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy.
Corrado Tinterri, Giuseppe Canavese, Paolo Bruzzi, Beatrice Dozin.
Contemp Clin Trials Commun, 2019 Dec 25; 17. PMID: 31872159    Free PMC article.
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling.
Elena Vissio, Jasna Metovic, +7 authors, Isabella Castellano.
Br J Cancer, 2019 Nov 30; 122(3). PMID: 31780778    Free PMC article.
De-escalation treatment of axilla in breast cancer.
G Corso, V Galimberti, P Veronesi.
Clin Transl Oncol, 2019 May 11; 22(3). PMID: 31073973
Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
Audree B Tadros, Tracy-Ann Moo, +3 authors, Monica Morrow.
Breast Cancer Res Treat, 2020 Jan 16; 180(1). PMID: 31938938    Free PMC article.
A New Model Incorporating Axillary Ultrasound After Neoadjuvant Chemotherapy to Predict Non-Sentinel Lymph Node Metastasis in Invasive Breast Cancer.
Kai Zhang, Qian Zhu, +2 authors, Cai Chang.
Cancer Manag Res, 2020 Feb 28; 12. PMID: 32104078    Free PMC article.
Role of Axillary Surgery After Neoadjuvant Chemotherapy.
Francisco Pimentel Cavalcante, Eduardo C Millen, Felipe P Zerwes, Guilherme G Novita.
JCO Glob Oncol, 2020 Feb 20; 6. PMID: 32073911    Free PMC article.
ASO Author Reflections: Intraoperative Nomograms Based on One-Step Nucleic Acid Amplification.
Kenzo Shimazu, Shinzaburo Noguchi.
Ann Surg Oncol, 2018 Oct 28; 25(Suppl 3). PMID: 30367299    Free PMC article.
Treatment of false-negative metastatic lymph nodes by a lymphatic drug delivery system with 5-fluorouracil.
Honoka Fujii, Sachiko Horie, +4 authors, Tetsuya Kodama.
Cancer Med, 2019 Apr 05; 8(5). PMID: 30945479    Free PMC article.
Risk factors and a predictive nomogram for non-sentinel lymph node metastases in Chinese breast cancer patients with one or two sentinel lymph node macrometastases and mastectomy.
X Y Wang, J T Wang, +6 authors, J Wang.
Curr Oncol, 2019 May 03; 26(2). PMID: 31043829    Free PMC article.
Outcomes of Sentinel Lymph Node Biopsy Using Blue Dye Method for Early Breast Cancer - A Single-Institution Experience in the Philippines.
Ralph Victor Yap, Frances Marion De La Serna.
Breast Cancer (Dove Med Press), 2020 Mar 27; 12. PMID: 32210610    Free PMC article.
De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
J M Simons, L B Koppert, +5 authors, M L Smidt.
Breast Cancer Res Treat, 2020 Mar 18; 180(3). PMID: 32180074    Free PMC article.
Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations.
Matthew S Katz, Linda McCall, +3 authors, Armando E Giuliano.
Breast Cancer Res Treat, 2020 Feb 12; 180(2). PMID: 32043193    Free PMC article.
Dosimetric comparison of incidental axillary irradiation between three-dimensional conformal and volumetric modulated arc techniques for breast cancer.
In Young Jo, Eun Seog Kim, +2 authors, Seung-Gu Yeo.
Mol Clin Oncol, 2020 Apr 28; 12(6). PMID: 32337037    Free PMC article.
The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.
Ismail Jatoi, Mitchell H Gail.
JAMA Oncol, 2019 Dec 13; 6(3). PMID: 31830235    Free PMC article.
5-ALA-assistant automated detection of lymph node metastasis in gastric cancer patients.
Tatsuya Matsumoto, Yasutoshi Murayama, +6 authors, Eigo Otsuji.
Gastric Cancer, 2020 Feb 13; 23(4). PMID: 32048096    Free PMC article.
Trends in utilization of sentinel node biopsy and adjuvant radiation in women ≥ 70.
Jinny Gunn, Riccardo Lemini, +6 authors, Emmanuel Gabriel.
Breast J, 2020 Jan 08; 26(7). PMID: 31908095    Free PMC article.
Modern surgical treatment of breast cancer.
M Riis.
Ann Med Surg (Lond), 2020 Jul 09; 56. PMID: 32637082    Free PMC article.
Review.
Locoregional Management After Neoadjuvant Chemotherapy.
Monica Morrow, Atif J Khan.
J Clin Oncol, 2020 May 23; 38(20). PMID: 32442069    Free PMC article.
Review.
The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease.
Mausam Patel, Chenghui Li, +4 authors, Thomas Kim.
Breast, 2020 Mar 28; 51. PMID: 32213441    Free PMC article.
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019.
Nina Ditsch, Michael Untch, +42 authors, Achim Wöckel.
Breast Care (Basel), 2019 Sep 29; 14(4). PMID: 31558897    Free PMC article.
Review.
Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer.
Olga Kantor, Stephanie Wong, +3 authors, Tari A King.
NPJ Breast Cancer, 2020 Aug 22; 6. PMID: 32821803    Free PMC article.
Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
Zhuanbo Yang, Xiaowen Lan, +14 authors, Shulian Wang.
Breast, 2020 Aug 22; 53. PMID: 32823167    Free PMC article.
Management of the Axilla after Neoadjuvant Systemic Therapy.
Trista J Stankowski-Drengler, Heather B Neuman.
Curr Treat Options Oncol, 2020 May 29; 21(7). PMID: 32462230    Free PMC article.
Review.
Surgical Management of the Axilla in Elderly Women With Node-Positive Breast Cancer.
Caitlin E Marks, Yi Ren, +7 authors, Jennifer K Plichta.
J Surg Res, 2020 Jun 02; 254. PMID: 32480072    Free PMC article.
Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer.
Chun-Fa Chen, Yu-Ling Zhang, +6 authors, De Zeng.
Front Oncol, 2019 Jan 24; 8. PMID: 30671386    Free PMC article.
Axillary management still needed for patients with sentinel node micrometastases.
Bin-Bin Cong, Jin-Ming Yu, Yong-Sheng Wang.
Cancer Manag Res, 2019 Mar 19; 11. PMID: 30881133    Free PMC article.
Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20-23 March 2019: personalised treatments for patients with early breast cancer.
Consuelo Morigi.
Ecancermedicalscience, 2019 Jul 10; 13. PMID: 31281421    Free PMC article.
Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients?
Kwang Hyun Yoon, Seho Park, +4 authors, Byeong-Woo Park.
Ann Surg Treat Res, 2019 Aug 08; 97(2). PMID: 31388507    Free PMC article.
Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer.
Xu Guo, Zhenyu Liu, +9 authors, Jiawei Tian.
EBioMedicine, 2020 Sep 28; 60. PMID: 32980697    Free PMC article.
Challenge for Diagnostic Assessment of Deep Learning Algorithm for Metastases Classification in Sentinel Lymph Nodes on Frozen Tissue Section Digital Slides in Women with Breast Cancer.
Young-Gon Kim, In Hye Song, +21 authors, Gyungyub Gong.
Cancer Res Treat, 2020 Jul 01; 52(4). PMID: 32599974    Free PMC article.
External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis.
Gilles Houvenaeghel, Houssein El Hajj, +17 authors, The Serc Trial Group.
Cancers (Basel), 2020 Oct 15; 12(10). PMID: 33050650    Free PMC article.
Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
Fabian Riedel, Joerg Heil, +7 authors, André Hennigs.
Breast Cancer Res Treat, 2020 Aug 21; 184(2). PMID: 32816190    Free PMC article.
Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?
Sung Mi Jung, Jinsun Woo, +7 authors, Jeong Eon Lee.
Ann Surg Treat Res, 2020 Nov 10; 99(5). PMID: 33163454    Free PMC article.
Comparison of indocyanine green fluorescence and methylene blue dye in the detection of sentinel lymph nodes in breast cancer.
Zhenghui Wang, Yangyang Cui, +5 authors, Shui Wang.
Gland Surg, 2020 Nov 24; 9(5). PMID: 33224824    Free PMC article.
Sentinel lymph node biopsy should be considered for clinically node-negative breast cancer regardless of BRCA1/2 mutation status.
Xin Huang, Jia-Qi Liu, +6 authors, Qiang Sun.
Ann Transl Med, 2020 Nov 27; 8(18). PMID: 33241032    Free PMC article.
Update Breast Cancer 2019 Part 3 - Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel.
Hans-Christian Kolberg, Andreas Schneeweiss, +18 authors, Sara Y Brucker.
Geburtshilfe Frauenheilkd, 2019 Jun 01; 79(5). PMID: 31148847    Free PMC article.
Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer.
Y Andersson, L Bergkvist, J Frisell, J de Boniface.
Breast Cancer Res Treat, 2019 Jun 27; 177(2). PMID: 31236811    Free PMC article.
A negative binomial regression model for risk estimation of 0-2 axillary lymph node metastases in breast cancer patients.
De Zeng, Hao-Yu Lin, +4 authors, Chun-Fa Chen.
Sci Rep, 2020 Dec 16; 10(1). PMID: 33318591    Free PMC article.
Redefining Criteria to Ensure Adequate Sentinel Lymph Node Biopsy With Dual Tracer for Breast Cancer.
Li Xu, Jiqiao Yang, +6 authors, Qing Lv.
Front Oncol, 2020 Dec 22; 10. PMID: 33344240    Free PMC article.
Axillary surgery for breast cancer: past, present, and future.
Masakuni Noguchi, Masafumi Inokuchi, +3 authors, Tomoko Kurita.
Breast Cancer, 2020 Nov 10; 28(1). PMID: 33165758
Review.
Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study.
Alejandra García-Novoa, Benigno Acea-Nebril, +10 authors, Joaquin Mosquera Oses.
Ann Surg Oncol, 2020 Jul 30; 28(2). PMID: 32725521
Identification of Risk Factors Associated with Axillary Lymph Node Metastasis for Sentinel Lymph Node-Positive Breast Cancer Patients.
Zhen He, Xiaowen Lan, +5 authors, Fan Yang.
J Oncol, 2021 Jan 19; 2020. PMID: 33456464    Free PMC article.
Predictive Factors Among Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in T1-T2 Breast Cancer.
Shigeki Minami, Chika Sakimura, +3 authors, Tsuyoshi Ohno.
Cancer Manag Res, 2021 Jan 21; 13. PMID: 33469365    Free PMC article.
Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer.
Shan Yang, Hong-Yu Xiang, +9 authors, Yin-Hua Liu.
Chin Med J (Engl), 2021 Feb 02; 134(3). PMID: 33522727    Free PMC article.
Preoperative Contrast-Enhanced Ultrasound (CEUS) Combined with 125I Seeds Localization in Sentinel Lymph Node Biopsy for Breast Cancer.
Pengpeng Zhou, Weizhen Zheng, Yanbing Liu, Yongsheng Wang.
Cancer Manag Res, 2021 Mar 05; 13. PMID: 33658849    Free PMC article.
Impact of the extent of axillary surgery in patients with N2-3 disease in the de-escalation era: a propensity score-matched study.
Y Kong, A Yang, +5 authors, W Wei.
Clin Transl Oncol, 2020 Jul 08; 23(3). PMID: 32632654
Predictive risk factors for sentinel lymph node metastasis using preoperative contrast-enhanced ultrasound in early-stage breast cancer patients.
Jianghua Qiao, Juntao Li, +3 authors, Zhenduo Lu.
Gland Surg, 2021 Mar 13; 10(2). PMID: 33708558    Free PMC article.
Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer.
R V Dave, S Cheung, +3 authors, A Gandhi.
BJS Open, 2021 Mar 11; 5(2). PMID: 33688940    Free PMC article.
Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis.
Shinsuke Sasada, Norio Masumoto, +3 authors, Morihito Okada.
Breast Cancer, 2021 Mar 20;. PMID: 33740208
Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
Matthew Castelo, Shu Yang Hu, +2 authors, Adena S Scheer.
Ann Surg Oncol, 2020 Feb 06; 27(8). PMID: 32020394
Systematic Review.
Association between the platelet to lymphocyte ratio, neutrophil to lymphocyte ratio and axillary lymph node metastasis in cT1N0 breast cancer patients.
Li Yang, Hongbiao Wang, +4 authors, Bin Wang.
Am J Transl Res, 2021 Apr 13; 13(3). PMID: 33841711    Free PMC article.
Axillary management in early breast cancer with onset surgical management and positive sentinel lymph node.
Lia Pamela Rebaza Vasquez, Jaime Ponce de la Torre, +2 authors, Henry Gomez Moreno.
Ecancermedicalscience, 2021 Apr 24; 15. PMID: 33889202    Free PMC article.
Review.
Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021.
Jing-Ming Ye, Bao-Liang Guo, +11 authors, Chinese Society of Breast Surgery.
Chin Med J (Engl), 2021 Apr 05; 134(8). PMID: 33813512    Free PMC article.
Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.
Jung Whan Chun, Jisun Kim, +6 authors, Sae Byul Lee.
Sci Rep, 2021 Apr 29; 11(1). PMID: 33907236    Free PMC article.
Preoperative Nomogram for Predicting Sentinel Lymph Node Metastasis Risk in Breast Cancer: A Potential Application on Omitting Sentinel Lymph Node Biopsy.
Xi'E Hu, Jingyi Xue, +7 authors, Guoqiang Bao.
Front Oncol, 2021 May 14; 11. PMID: 33981613    Free PMC article.
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials.
Maria Luisa Gasparri, Thorsten Kuehn, +14 authors, Oreste D Gentilini.
Cancers (Basel), 2021 May 01; 13(9). PMID: 33923153    Free PMC article.
Review.
Targeted Axillary Dissection in Node-Positive Breast Cancer: A Retrospective Study and Cost Analysis.
Michèle Beniey, Kerianne Boulva, +3 authors, Erica Patocskai.
Cureus, 2021 May 28; 13(4). PMID: 34040910    Free PMC article.
Application of fluorescein combined with methylene blue in sentinel lymph node biopsy of breast cancer.
Liang Li, Ning Gao, +5 authors, Jia Qi Liu.
Sci Rep, 2021 Jun 11; 11(1). PMID: 34108563